Literature DB >> 30095566

Addressing Workforce Needs for Medication Treatment of Opioid Use Disorder.

Cindy Parks Thomas1.   

Abstract

: Medication treatment of opioid use disorder (OUD) is recognized as an effective evidence-based treatment. It has been underused, in part due to challenges in recruiting and retaining a provider workforce that is able to prescribe and manage patients treated with OUD medications. A national goal should be: anyone with an OUD must have adequate access to a range of medications for treatment and support, provided in high-quality settings, and all programs receiving public or private funding should be so equipped. To accomplish this, it is important to understand what recruitment efforts are most successful, and what implementation strategies and service models are most effective. Building an adequate OUD treatment workforce, however, will require a system with adequate program resources and incentives, clinician and patient education to reduce stigma, limited regulatory burden, and adequate reimbursement and support high-quality services.

Entities:  

Year:  2019        PMID: 30095566     DOI: 10.1097/ADM.0000000000000442

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   3.702


  3 in total

1.  Opioid Use Disorder and Assessment of Patient Interactions Among Family Medicine Residents, Medical Students, and Physician Assistant Students.

Authors:  John G Spangler; Catherine N Shull; Carol A Hildebrandt; Keli Beck Jones; Andrew L Brewer; Mark P Knudson; Gail S Marion; Julienne K Kirk
Journal:  MedEdPORTAL       Date:  2020-11-12

Review 2.  Misalignment of Stakeholder Incentives in the Opioid Crisis.

Authors:  Alireza Boloori; Bengt B Arnetz; Frederi Viens; Taps Maiti; Judith E Arnetz
Journal:  Int J Environ Res Public Health       Date:  2020-10-16       Impact factor: 3.390

Review 3.  Financial sustainability of payment models for office-based opioid treatment in outpatient clinics.

Authors:  Dominic Hodgkin; Constance Horgan; Gavin Bart
Journal:  Addict Sci Clin Pract       Date:  2021-07-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.